Pertuzumab plus trastuzumab (P plus T) in patients (Pts) with colorectal cancer (CRC) with ERBB2 amplification or overexpression: Results from the TAPUR Study

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Gupta, R; Garrett-Mayer, E; Halabi, S; Mangat, PK; D'Andre, SD; Meiri, E; Shrestha, S; Warren, SL; Ranasinghe, S; Schilsky, RL

Published Date

  • February 1, 2020

Published In

Volume / Issue

  • 38 / 4

Electronic International Standard Serial Number (EISSN)

  • 1527-7755

International Standard Serial Number (ISSN)

  • 0732-183X